NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,946,369 | +14.0% | 235,091 | +12.9% | 0.04% | +14.7% |
| Q2 2023 | $21,003,911 | +11.6% | 208,145 | +1.7% | 0.03% | +6.2% |
| Q1 2023 | $18,824,856 | -10.5% | 204,618 | -11.8% | 0.03% | -13.5% |
| Q4 2022 | $21,036,062 | +44.6% | 231,879 | +21.2% | 0.04% | +23.3% |
| Q3 2022 | $14,545,000 | -33.4% | 191,342 | -25.9% | 0.03% | -28.6% |
| Q2 2022 | $21,834,000 | +5.0% | 258,296 | +9.0% | 0.04% | +20.0% |
| Q1 2022 | $20,785,000 | -3.9% | 236,862 | -4.2% | 0.04% | +2.9% |
| Q4 2021 | $21,639,000 | -13.1% | 247,372 | -18.7% | 0.03% | -27.7% |
| Q3 2021 | $24,887,000 | -15.7% | 304,305 | -6.0% | 0.05% | -14.5% |
| Q2 2021 | $29,528,000 | +13.6% | 323,621 | +6.4% | 0.06% | +3.8% |
| Q1 2021 | $26,001,000 | -6.8% | 304,177 | +2.9% | 0.05% | -11.7% |
| Q4 2020 | $27,911,000 | +11.4% | 295,571 | +2.6% | 0.06% | -1.6% |
| Q3 2020 | $25,047,000 | -9.1% | 288,035 | -8.7% | 0.06% | -15.3% |
| Q2 2020 | $27,560,000 | +4.1% | 315,538 | -1.7% | 0.07% | -13.3% |
| Q1 2020 | $26,469,000 | +15.1% | 321,043 | +32.2% | 0.08% | +40.7% |
| Q4 2019 | $22,994,000 | +11.2% | 242,833 | +2.1% | 0.06% | +5.4% |
| Q3 2019 | $20,674,000 | +15.5% | 237,923 | +21.4% | 0.06% | +12.0% |
| Q2 2019 | $17,901,000 | -17.9% | 196,047 | -13.6% | 0.05% | -20.6% |
| Q1 2019 | $21,814,000 | -13.5% | 226,897 | -22.8% | 0.06% | -22.2% |
| Q4 2018 | $25,222,000 | +17.8% | 293,928 | +18.3% | 0.08% | +30.6% |
| Q3 2018 | $21,410,000 | +29.0% | 248,494 | +13.1% | 0.06% | +21.6% |
| Q2 2018 | $16,591,000 | -1.2% | 219,644 | +5.8% | 0.05% | -1.9% |
| Q1 2018 | $16,787,000 | -16.7% | 207,635 | -13.5% | 0.05% | -16.1% |
| Q4 2017 | $20,152,000 | +7.1% | 240,011 | +9.5% | 0.06% | +3.3% |
| Q3 2017 | $18,822,000 | -0.0% | 219,233 | -2.8% | 0.06% | -4.8% |
| Q2 2017 | $18,828,000 | -19.1% | 225,559 | -28.0% | 0.06% | -21.2% |
| Q1 2017 | $23,277,000 | -0.7% | 313,403 | -2.6% | 0.08% | -4.8% |
| Q4 2016 | $23,434,000 | +0.3% | 321,724 | +8.7% | 0.08% | -3.4% |
| Q3 2016 | $23,374,000 | +11.8% | 296,017 | +16.8% | 0.09% | +8.8% |
| Q2 2016 | $20,916,000 | +2.6% | 253,486 | -10.0% | 0.08% | 0.0% |
| Q1 2016 | $20,395,000 | -29.5% | 281,559 | -16.3% | 0.08% | -31.0% |
| Q4 2015 | $28,932,000 | -10.6% | 336,273 | -4.5% | 0.12% | -14.7% |
| Q3 2015 | $32,357,000 | -8.8% | 352,021 | -2.4% | 0.14% | -0.7% |
| Q2 2015 | $35,475,000 | +0.7% | 360,735 | +1.0% | 0.14% | +1.5% |
| Q1 2015 | $35,226,000 | +4.4% | 357,230 | -1.9% | 0.14% | +3.8% |
| Q4 2014 | $33,728,000 | +6.2% | 364,000 | +7.9% | 0.13% | +0.8% |
| Q3 2014 | $31,768,000 | +12.7% | 337,491 | +8.4% | 0.13% | +15.2% |
| Q2 2014 | $28,182,000 | +14.4% | 311,296 | +7.5% | 0.11% | +10.9% |
| Q1 2014 | $24,630,000 | +9.1% | 289,699 | +3.1% | 0.10% | +11.0% |
| Q4 2013 | $22,581,000 | +10.7% | 280,932 | +5.6% | 0.09% | +1.1% |
| Q3 2013 | $20,401,000 | +4.5% | 265,949 | -3.6% | 0.09% | +1.1% |
| Q2 2013 | $19,515,000 | – | 275,979 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |